Mrv0541 04191212102D 10 10 0 0 0 0 999 V2000 -0.1480 0.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1480 -0.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8625 0.6169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5665 0.6169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8625 -1.0331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5770 0.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2809 0.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5770 -0.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2809 -0.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9954 0.6169 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 2 0 0 0 0 1 4 1 0 0 0 0 2 5 2 0 0 0 0 3 6 1 0 0 0 0 4 7 1 0 0 0 0 5 8 1 0 0 0 0 7 9 1 0 0 0 0 7 10 1 0 0 0 0 6 8 2 0 0 0 0 M END > T3D2706 > t3db > CC(N)CC1=CC=CC=C1 > InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3 > KWTSXDURSIMDCE-UHFFFAOYSA-N > C9H13N > 135.2062 > 135.104799421 > 1 > 16.174738885675872 > 1 > 1 > 0 > 0 > 1-phenylpropan-2-amine > 1.85 > 1.8042504816666665 > -1.89 > 0 > 1 > 1 > 10.01443581771614 > 26.02 > 43.7052 > 2 > 1 > 1.74e+00 g/l > adderall > 1 > T3D2706 > Amphetamine > 300-62-9 > (+/-)-Benzedrine; (+/-)-beta-Phenylisopropylamine; (+/-)-Desoxynorephedrine; 1-Methyl-2-phenylethylamine; 1-Phenyl-2-aminopropane; 1-Phenylpropan-2-amin; 3-Methoxyamphetamine; alpha-Methylbenzeneethaneamine; alpha-Methylphenylethylamine; Amfetamine; Amfetaminum; Amphetamin; Amphetamine Sulfate; beta-Aminopropylbenzene; beta-Phenyl-isopropylamine; beta-Phenylisopropylamin; beta-Phenylisopropylamine; Desoxynorephedrine; Dl-1-Phenyl-2-aminopropane; DL-alpha-Methylphenethylamine; Dl-Amphetamine; Dl-Benzedrine; Fenylo-izopropylaminyl; m-Methoxyamphetamine; Methamphetamine HCL; [1-(3-Methoxyphenyl)-2-propyl]amine; α-methylbenzeneethaneamine; α-methylphenethylamine; β-aminopropylbenzene; β-phenylisopropylamine > Organic Compound; Amine; Drug; Adrenergic Uptake Inhibitor; Dopamine Agent; Adrenergic Agent; Amphetamine; Central Nervous System Stimulant; Dopamine Uptake Inhibitor; Sympathomimetic; Metabolite; Synthetic Compound $$$$